Type A2 botulinum toxin preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9623075
SERIAL NO

13903731

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for treating a patient who has a neutralizing antibody to a type A1 botulinum toxin. The method includes administering 150 kDa type A neurotoxin from type A2 Clostridium botulinum (A2 NTX) to the patient. In accordance with the present invention, a problem can be solved of decrease in clinical response caused by a neutralizing antibody to a type A1 botulinum toxin produced when a patient is treated with a pharmaceutical preparation containing a type A1 botulinum toxin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KM BIOLOGICS CO LTD1-6-1 OKUBO KITA-KU KUMAMOTO-SHI KUMAMOTO 8608568 ?8608568

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goto, Yoshitaka Kumamoto, JP 23 160
Kozaki, Shunji Sakai, JP 10 126
Munechika, Satomi Kumamoto, JP 2 4
Nakahira, Shinji Kumamoto, JP 3 15
Okuda, Sachio Kumamoto, JP 6 11
Shinmura, Miho Kumamoto, JP 3 6
Torii, Yasushi Kumamoto, JP 12 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00